TrialAmerican journal of therapeutics

Metformin plus low-dose glimeperide significantly improves Homeostasis Model Assessment for insulin resistance (HOMA(IR)) and beta-cell function (HOMA(beta-cell)) without hyperinsulinemia in patients with type 2 diabetes mellitus.

Valmore J Bermúdez-Pirela et al.PubMed ↗Publisher ↗

No numbers read from the abstract.